Anteris Technologies Global 

A$7.8
20
+A$0.21+2.77% Today

Statistics

Day High
7.86
Day Low
7.65
52W High
9.79
52W Low
4.26
Volume
9,169
Avg. Volume
17,646
Mkt Cap
321.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 7
A$0.06
Sep 6
A$0.05
Mar 6
A$0.04
Oct 5
A$0.04
Apr 5
A$0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.65
-1.17
-0.7
-0.22
Expected EPS
-0.22256249554875016
Actual EPS
N/A

Financials

-2,831.12%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8.37MRevenue
-236.97MNet Income

Analyst Ratings

17.85Average Price Target
The highest estimate is 18.43.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AVR.AU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap45.23B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, directly competing with Anteris's focus on cardiovascular devices.
Medtronic
MDT
Mkt Cap111.97B
Medtronic offers a broad range of medical devices including those for cardiovascular therapy, competing in similar markets as Anteris Technologies.
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific produces medical devices used in interventional medical specialties, including cardiovascular, competing with Anteris's product offerings.
Abbott Laboratories
ABT
Mkt Cap174.29B
Abbott Laboratories has a wide range of medical devices, including for cardiovascular health, making it a competitor in the same space as Anteris.
Stryker
SYK
Mkt Cap129.89B
Stryker Corporation is involved in medical technologies, including surgical equipment and neurovascular products, indirectly competing with Anteris's focus areas.
Zimmer Biomet
ZBH
Mkt Cap18.22B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in medical devices place it as a competitor in the broader medical device market.
Intuitive Surgical
ISRG
Mkt Cap160.05B
Intuitive Surgical, known for its robotic surgical systems, competes in the innovative medical device space, indirectly affecting companies like Anteris.
Baxter International
BAX
Mkt Cap8.85B
Baxter International develops, manufactures, and markets healthcare products, including hospital and renal care products, competing in the healthcare solutions sector.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson's medical device segment offers a broad range of products that compete across various sectors, including cardiovascular.
Integra Lifesciences
IART
Mkt Cap725.6M
Integra LifeSciences, a provider of regenerative technologies, surgical instrumentation, and neurosurgical products, competes in the medical technology and device market.

About

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Show more...
CEO
Mr. Wayne Geoffrey Paterson
Employees
174
Country
Australia
ISIN
AU0000088841

Listings

0 Comments

Share your thoughts

FAQ

What is Anteris Technologies Global stock price today?
The current price of AVR.AU is A$7.8 AUD — it has increased by +2.77% in the past 24 hours. Watch Anteris Technologies Global stock price performance more closely on the chart.
What is Anteris Technologies Global stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Anteris Technologies Global stocks are traded under the ticker AVR.AU.
Is Anteris Technologies Global stock price growing?
AVR.AU stock has risen by +3.31% compared to the previous week, the month change is a -14.29% fall, over the last year Anteris Technologies Global has showed a +60.82% increase.
What is Anteris Technologies Global market cap?
Today Anteris Technologies Global has the market capitalization of 321.34M
When is the next Anteris Technologies Global earnings date?
Anteris Technologies Global is going to release the next earnings report on May 19, 2026.
What were Anteris Technologies Global earnings last quarter?
AVR.AU earnings for the last quarter are -1.04 AUD per share, whereas the estimation was -0.71 AUD resulting in a -47.02% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is Anteris Technologies Global revenue for the last year?
Anteris Technologies Global revenue for the last year amounts to 8.37M AUD.
What is Anteris Technologies Global net income for the last year?
AVR.AU net income for the last year is -236.97M AUD.
Does Anteris Technologies Global pay dividends?
Yes, AVR.AU dividends are paid semi-annual. The last dividend per share was 0.06 AUD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Anteris Technologies Global have?
As of April 13, 2026, the company has 174 employees.
In which sector is Anteris Technologies Global located?
Anteris Technologies Global operates in the Health & Wellness sector.
When did Anteris Technologies Global complete a stock split?
Anteris Technologies Global has not had any recent stock splits.
Where is Anteris Technologies Global headquartered?
Anteris Technologies Global is headquartered in Toowong, Australia.